Cribstone Capital Management’s AstraZeneca AZN Stock Holding History

Cribstone Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	–	–	338
2021 Q1	$0	Hold	3	–	–	﹤0.01%	329
2020 Q4	$0	Hold	3	–	–	﹤0.01%	320
2020 Q3	$0	Hold	3	–	–	﹤0.01%	298
2020 Q2	$0	Buy	+3	New	+$310	﹤0.01%	346
2020 Q1	–	Sell	-25	Closed	-$2K	–	346
2019 Q4	$2K	Hold	25	–	–	﹤0.01%	339
2019 Q3	$2K	Sell	25 -100	-80%	-$8.67K	﹤0.01%	520
2019 Q2	$10K	Sell	125 -50	-29%	-$3.92K	0.01%	444
2019 Q1	$14K	Hold	175	–	–	0.01%	416
2018 Q4	$13K	Hold	175	–	–	0.01%	427
2018 Q3	$14K	Hold	175	–	–	0.01%	457
2018 Q2	$12K	Hold	175	–	–	0.01%	477
2018 Q1	$12K	Hold	175	–	–	0.01%	469
2017 Q4	$12K	Hold	175	–	–	0.01%	535
2017 Q3	$12K	Hold	175	–	–	0.01%	473
2017 Q2	$12K	Hold	175	–	–	0.01%	474
2017 Q1	$11K	Sell	175 -25	-13%	-$1.46K	0.01%	516
2016 Q4	$11K	Sell	200 -120	-38%	-$6.81K	0.01%	478
2016 Q3	$20K	Hold	320	–	–	0.01%	402
2016 Q2	$19K	Buy	+320	New	+$18.6K	0.01%	426

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cribstone Capital Management's AZN Position: Q2 2021 in Review

Cribstone Capital Management sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 3 shares.

Cribstone Capital Management first reported a position in AZN in Q2 2016 and held it in 19 quarters. The position peaked at $20K in Q3 2016. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

Cribstone Capital Management reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
Cribstone Capital Management sold 3 AstraZeneca shares in Q2 2021.
Cribstone Capital Management first reported a position in AstraZeneca in Q2 2016 and held it in 19 quarters.
Cribstone Capital Management's AstraZeneca position peaked at $20K in Q3 2016.
771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Cribstone Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.